BioPharma Dive Jan 5, 2026 Zenas shares crash after top drug misses expectations in immune disease study
FierceBiotech Jan 5, 2026 Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit
FierceBiotech Jan 5, 2026 Abbott launches AI-based Libre Assist, its new in-app feature for meal planning
Thermo Fisher Jan 5, 2026 Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)? - Yahoo Finance
Thermo Fisher Jan 5, 2026 14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat
PLoS Biology Jan 5, 2026 Characterization of RNA interference in the cnidarian <i>Nematostella vectensis</i> reveals partial target silencing but lack of small RNA amplification
PLoS Biology Jan 5, 2026 The Rho GTPase regulator ARHGEF3 orchestrates hair placode budding by coordinating cell fate and P-cadherin patterning in mice
PLoS Biology Jan 5, 2026 MMSpa is a deep learning-based tool that enhances the identification of spatial domains in spatial transcriptomics studies
PLoS Biology Jan 5, 2026 Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms